Biofrontera Inc.

NASDAQ: BFRI · Real-Time Price · USD
0.94
-0.03 (-2.69%)
At close: Aug 15, 2025, 12:22 PM

Biofrontera Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
7.24M 1.78M 5.91M 2.87M 4.38M 3.82M 1.34M 3.42M 4.45M 13.51M 17.21M 27.52M 31.91M 22.43M 24.55M 1.72M 3.05M 4.64M
Short-Term Investments
n/a 7K 7K 8K 10K 23K 78K 3.34M 5.93M 7.6M 10.55M n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a 200K 200K 200K n/a n/a n/a 2.81M 2.81M 2.81M 2.81M 2.81M n/a n/a n/a
Other Long-Term Assets
535K 453K 383K 383K 124K 128K 282K 692K 504K 384K 3.13M 3.21M 3.16M 268K 268K 1.37M 992K 596K
Receivables
3.96M 4.03M 5.32M 4.87M 3.5M 3.69M 5.16M 6.51M 6.19M 7.87M 7.41M 8.08M 5.05M 13.86M 3.78M 2.04M 1.78M 1.91M
Inventory
4.03M 6.53M 6.65M 6.53M 3.95M 6.91M 10.91M 16.07M 14.79M 6.67M 7.17M 12.09M 8.81M 4.87M 4.46M 5.44M 6.72M 8.43M
Other Current Assets
3.59M 2.98M 2.83M 2.65M 5.63M 5.72M 5.28M 274K 929K 58K 371K 346K 615K 650K 12.81M 546K 609K 571K
Total Current Assets
18.82M 15.33M 20.7M 16.93M 17.47M 20.16M 23.07M 29.61M 32.3M 37.22M 43.14M 48.49M 46.98M 42.53M 46.42M 10.14M 12.73M 16.1M
Property-Plant & Equipment
766K 772K 983K 1.16M 1.33M 1.54M 1.75M 1.28M 1.28M 1.43M 1.58M 224K 248K 245K 267K 289K 314K 334K
Goodwill & Intangibles
26K 31K 35K 39K 2.45M 2.56M 2.63M 2.72M 2.82M 2.93M 3.03M 3.14M 3.24M 3.35M 3.45M 3.56M 3.66M 3.76M
Total Long-Term Assets
1.33M 1.26M 1.4M 1.58M 4.1M 4.42M 4.86M 4.49M 4.61M 4.74M 7.74M 6.57M 6.64M 6.67M 6.8M 5.22M 4.96M 4.69M
Total Assets
20.14M 16.59M 22.1M 18.52M 21.57M 24.57M 27.93M 34.1M 36.91M 41.97M 50.88M 55.06M 53.63M 49.2M 53.22M 15.35M 17.7M 20.8M
Account Payables
4.27M 3.3M 1.86M 2.03M 4.58M 6.66M 9.01M 8.62M 5.9M 1.8M 2.59M 4.46M 2.22M 571K 940K 367K 932K 615K
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a 7.21M 7.12M 7.03M 6.94M 3.24M 3.24M 3.24M 3.24M n/a n/a n/a
Short-Term Debt
443K n/a n/a 670K 296K 2.35M 3.9M 1.7M 1.59M 484K n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Liabilities
19.24M 3.99M 1.05M 6.99M 3.3M 556K 3.02M 8.09M 6.27M 6.19M 6.66M 6.52M 6.45M 6.59M 6.7M 6.57M 2.76M 1.59M
Total Current Liabilities
19.69M 10.96M 12.02M 11.03M 9.27M 14.04M 18.09M 29.12M 25.35M 20.45M 20.89M 17.14M 14.88M 12.36M 13.84M 11.29M 4.03M 4.05M
Long-Term Debt
4.56M 4.22M 4.1M n/a n/a 3.57M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
562K 723K 1.27M 1.63M 952K 11.76M 4.25M 880K 1.48M 1.84M 2.86M 15.32M 21.52M 19.43M 18.5M 21.44M 26K 36K
Total Long-Term Liabilities
5.12M 5.16M 5.65M 1.95M 1.4M 15.96M 5.05M 3.94M 4.38M 4.76M 6.11M 15.32M 21.52M 19.43M 28.05M 21.44M 15.03M 14.45M
Total Liabilities
24.81M 16.12M 17.67M 12.99M 10.66M 29.99M 23.14M 33.07M 29.73M 25.21M 27M 32.46M 36.39M 31.79M 41.88M 32.73M 19.06M 18.5M
Total Debt
5M 4.86M 4.92M 994K 1.44M 7.24M 5.4M 2.81M 2.19M 1.21M 1.35M n/a n/a n/a n/a n/a n/a n/a
Common Stock
9K 9K 9K 7K 5K 5K 2K 1K 27K 27K 27K 23K 19K 17K 17K 8K 8K 8K
Retained Earnings
-126.94M -121.61M -117.41M -116.01M -110.34M -110.09M -99.65M -103.18M -96.83M -87M -79.52M -76.73M -74.17M -73.32M -78.88M -64.37M -48.36M -44.7M
Comprehensive Income
n/a n/a n/a n/a n/a -3.57M n/a n/a n/a n/a n/a n/a n/a n/a 0.00 n/a n/a 0.00
Shareholders Equity
-4.67M 469K 4.43M 5.53M 10.91M -5.42M 4.79M 1.04M 7.17M 16.75M 23.88M 22.59M 17.23M 17.42M 11.34M -17.38M -1.37M 2.29M
Total Investments
n/a 7K 7K 8K 10K 223K 278K 3.34M 5.93M 7.6M 10.55M 2.81M 2.81M 2.81M 2.81M n/a n/a n/a